Clinical Trials Browser

Phase 1 × Completed × Solid Tumors × Clear all

NCT04261413 2026-03-11

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT05372367 2026-02-03

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT03762447 2025-08-11

A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT06873542 2025-03-12

A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01251562 2025-02-19

Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02667873 2025-02-10

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT05613036 2025-01-22

A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02610361 2024-12-27

Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00909025 2024-11-21

Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02699515 2024-11-18

MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors

Phase 1 Completed

114 enrolled 29 charts

Other solid neoplasm

Solid Tumors

NCT02038673 2024-10-31

An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT03641586 2024-10-23

The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01286467 2024-03-06

A Study Of PF-04449913 Administered Alone In Select Solid Tumors

Phase 1 Completed

23 enrolled 26 charts

Other solid neoplasm

Solid Tumors

NCT04857138 2024-02-05

A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00648648 2023-09-21

MK-1775-001

Phase 1 Completed

206 enrolled 40 charts

Other solid neoplasm

Solid Tumors

NCT05877651 2023-05-30

MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT04341259 2023-05-08

A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01379287 2023-02-02

Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT04653142 2022-05-10

A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00702494 2022-03-16

Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT03101488 2022-03-03

Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02705963 2022-02-09

A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02660034 2021-12-06

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

Phase 1 Completed

229 enrolled 46 charts

Other solid neoplasm

Solid Tumors

NCT01922752 2021-11-12

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT03006029 2021-10-06

TAB08

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02478866 2021-09-16

Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02533674 2021-06-11

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

Phase 1 Completed

57 enrolled 19 charts

Other solid neoplasm

Solid Tumors

NCT02827968 2021-06-02

Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01222637 2021-05-25

CetuGEX™: Phase 1 Study in Cancer Patients

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01222624 2021-05-20

PankoMab-GEX™: Phase 1 Dose Escalation Study

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02499224 2021-05-13

Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01409343 2021-05-07

TrasGEX™: Phase 1 Study in Cancer Patients

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01443481 2020-12-21

Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01240655 2020-12-19

A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02078349 2020-09-10

Phase I Study of KPT330 in Asian Patients

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01277146 2020-09-09

A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01957007 2020-09-09

A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02916095 2020-09-03

Kanitinib in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02881138 2020-07-30

A Study of RC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT04118842 2020-04-03

A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02650713 2020-02-12

A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02304393 2019-12-13

A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00635284 2019-10-18

ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02748837 2019-08-22

A Study of ERY974 in Patient With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02058901 2019-07-17

Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT03362723 2019-06-19

A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02250781 2019-05-22

Oral ONC201 in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01341457 2019-03-01

A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors

Phase 1 Completed

17 enrolled 16 charts

Other solid neoplasm

Solid Tumors

NCT02301754 2019-02-26

INVAC-1 Anti-Cancer hTERT DNA Immunotherapy

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT01049893 2019-02-12

Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors